Post by account_disabled on Jan 2, 2024 5:40:04 GMT
Petaling is the second city in Asia to join the C/Can initiative - The decision comes a year after Malaysia hosted the World Cancer Congress - Malaysia has a relatively low cancer survival rate compared to countries with Other upper middle income groups today at the World Cancer Leaders' Summit 2019 in Nur-Sultan (formerly Astana), Kazakhstan It was announced that The Malaysian city of Petaling has joined the City Cancer Challenge (C/Can). The decision comes a year after Malaysia hosted the World Cancer Congress 2018 in Kuala Lumpur. and reflects the commitment of those involved in Malaysia to continue the success of the conference. To push for concrete measures to improve access to quality cancer care for all patients. Petaling joins forces with cities around the world to collaborate with a network of partners in various sectors.
In planning and delivering treatment solutions for Industry Email List cancer patients, Dr. Saunthari Somasundaram, President of the National Cancer Society of Malaysia, said, “We are extremely proud to have been selected to participate in the project. Malaysia has made continuous progress in developing its health system. This decision will allow us to make leaps and bounds in the care we provide to cancer patients.” Petaling is the second city in Asia to join the City Cancer Challenge, according to Dr. Aung Naing Soe, Program Director C/. Can, Asia Region, said: “The C/Can project is expanding its operations in Asia. As a result, cities There are more opportunities to build partnerships and share knowledge. We will continue the strong political resolve and civil society movement in Petaling. to improve access to quality cancer care both in Petaling and across the region.” The World Cancer Congress 2018 invited cities to join in Asia to join the C/Can initiative, and the city of Petaling has responded to the call. Supported by the National Cancer Society of Malaysia and Universiti Malaya, Petaling is comprised of the Petaling Jaya and Subang Jaya districts in Selangor. which is one of the most prosperous states in Malaysia and provides cancer treatment to more than 1.4 million people . Dr. Siti Mariah Binti Mahmud, Member of the Selangor State Council, said: “The C/Can project will combine the full potential of technology and the forward thinking of the city's people.
Petaling It fits with the local government's commitment to delivering efficient and equitable health services. We see great success ahead.” According to the latest data from the World Health Organization (WHO), Malaysia recorded 43,837 new cancer cases and 26,395 cancer-related deaths in 2018, with cancers at The top three are most common in men and women. (excluding non-melanoma skin cancer) including breast cancer Colon cancer and lung cancer (source: Globocan) Datuk Dr Noor Hisham Abdullah, Director-General of the Department of Health The Malaysian Ministry of Health said: “The Malaysian Ministry of Health welcomes the efforts of the C/Can project to join forces with the health and other sectors. To develop cutting-edge and customized cancer treatment solutions for local people. with the goal of tackling the growing burden of cancer.” Malaysia is a high-middle-income country. and have a stable health system But gaps remain in terms of access to timely diagnosis and treatment. Cancer survival rates are relatively low compared to other upper-middle-income countries. Dr. Nur Aishah Taib, Director of the UM Cancer Research Institute, said: “Under the City Cancer Challenge, we will improve the health system. Both public and private sectors are already established in Petaling City. To offer better health services In terms of timely diagnosis and treatment of disease This ultimately improves patient outcomes.
In planning and delivering treatment solutions for Industry Email List cancer patients, Dr. Saunthari Somasundaram, President of the National Cancer Society of Malaysia, said, “We are extremely proud to have been selected to participate in the project. Malaysia has made continuous progress in developing its health system. This decision will allow us to make leaps and bounds in the care we provide to cancer patients.” Petaling is the second city in Asia to join the City Cancer Challenge, according to Dr. Aung Naing Soe, Program Director C/. Can, Asia Region, said: “The C/Can project is expanding its operations in Asia. As a result, cities There are more opportunities to build partnerships and share knowledge. We will continue the strong political resolve and civil society movement in Petaling. to improve access to quality cancer care both in Petaling and across the region.” The World Cancer Congress 2018 invited cities to join in Asia to join the C/Can initiative, and the city of Petaling has responded to the call. Supported by the National Cancer Society of Malaysia and Universiti Malaya, Petaling is comprised of the Petaling Jaya and Subang Jaya districts in Selangor. which is one of the most prosperous states in Malaysia and provides cancer treatment to more than 1.4 million people . Dr. Siti Mariah Binti Mahmud, Member of the Selangor State Council, said: “The C/Can project will combine the full potential of technology and the forward thinking of the city's people.
Petaling It fits with the local government's commitment to delivering efficient and equitable health services. We see great success ahead.” According to the latest data from the World Health Organization (WHO), Malaysia recorded 43,837 new cancer cases and 26,395 cancer-related deaths in 2018, with cancers at The top three are most common in men and women. (excluding non-melanoma skin cancer) including breast cancer Colon cancer and lung cancer (source: Globocan) Datuk Dr Noor Hisham Abdullah, Director-General of the Department of Health The Malaysian Ministry of Health said: “The Malaysian Ministry of Health welcomes the efforts of the C/Can project to join forces with the health and other sectors. To develop cutting-edge and customized cancer treatment solutions for local people. with the goal of tackling the growing burden of cancer.” Malaysia is a high-middle-income country. and have a stable health system But gaps remain in terms of access to timely diagnosis and treatment. Cancer survival rates are relatively low compared to other upper-middle-income countries. Dr. Nur Aishah Taib, Director of the UM Cancer Research Institute, said: “Under the City Cancer Challenge, we will improve the health system. Both public and private sectors are already established in Petaling City. To offer better health services In terms of timely diagnosis and treatment of disease This ultimately improves patient outcomes.